Publications by authors named "Alexander Dowell-Day"

Background: During an evolving outbreak or pandemic, non-pharmaceutical interventions (NPIs) including physical distancing, isolation, and mask use may flatten the peak in communities. However, these strategies rely on community understanding and motivation to engage to ensure appropriate compliance and impact. To support current activities for COVID-19, the objectives of this narrative review was to identify the key determinants impacting on engagement.

View Article and Find Full Text PDF

Background: People who inject drugs (PWID) experience barriers to accessing testing and treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an opportunity to improve access to HCV care. This systematic review assessed the association of OAT and HCV testing, treatment, and treatment outcomes among PWID.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Alexander Dowell-Day"

  • - Alexander Dowell-Day's research primarily focuses on public health interventions, particularly in the context of infectious diseases such as COVID-19 and hepatitis C among vulnerable populations.
  • - His study on non-pharmaceutical interventions during the COVID-19 pandemic emphasizes the importance of community engagement and understanding in effective implementation and compliance.
  • - In a systematic review addressing opioid agonist therapy, Dowell-Day evaluates its potential to enhance testing and treatment access for hepatitis C among people who inject drugs, highlighting significant barriers they face.